ABHD4
Basic information
Region (hg38): 14:22598290-22612963
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABHD4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in ABHD4
This is a list of pathogenic ClinVar variants found in the ABHD4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-22601674-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
14-22601705-G-A | not specified | Uncertain significance (Oct 31, 2023) | ||
14-22603480-G-A | not specified | Uncertain significance (Nov 22, 2021) | ||
14-22603486-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
14-22603530-A-T | not specified | Uncertain significance (Mar 20, 2024) | ||
14-22603537-A-G | not specified | Uncertain significance (Apr 04, 2024) | ||
14-22603558-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
14-22603696-T-C | not specified | Uncertain significance (Jun 01, 2023) | ||
14-22603971-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
14-22603972-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
14-22603993-G-A | not specified | Uncertain significance (Mar 22, 2023) | ||
14-22603998-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
14-22604001-C-G | not specified | Uncertain significance (Aug 30, 2022) | ||
14-22604019-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
14-22606427-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
14-22606470-C-A | not specified | Uncertain significance (May 21, 2024) | ||
14-22609780-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
14-22609789-G-A | not specified | Uncertain significance (May 26, 2022) | ||
14-22609804-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
14-22609861-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
14-22610893-A-T | not specified | Uncertain significance (Mar 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABHD4 | protein_coding | protein_coding | ENST00000428304 | 7 | 14120 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.22e-8 | 0.698 | 125526 | 0 | 222 | 125748 | 0.000883 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.701 | 191 | 220 | 0.867 | 0.0000134 | 2242 |
Missense in Polyphen | 58 | 63.743 | 0.90991 | 637 | ||
Synonymous | -0.827 | 94 | 84.3 | 1.11 | 0.00000519 | 694 |
Loss of Function | 1.30 | 15 | 21.5 | 0.697 | 0.00000148 | 178 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000933 | 0.000928 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.00148 | 0.00148 |
European (Non-Finnish) | 0.00116 | 0.00115 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000625 | 0.000621 |
Other | 0.00131 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Lysophospholipase selective for N-acyl phosphatidylethanolamine (NAPE). Contributes to the biosynthesis of N-acyl ethanolamines, including the endocannabinoid anandamide by hydrolyzing the sn-1 and sn-2 acyl chains from N-acyl phosphatidylethanolamine (NAPE) generating glycerophospho-N-acyl ethanolamine (GP-NAE), an intermediate for N-acyl ethanolamine biosynthesis. Hydrolyzes substrates bearing saturated, monounsaturated, polyunsaturated N-acyl chains. Shows no significant activity towards other lysophospholipids, including lysophosphatidylcholine, lysophosphatidylethanolamine and lysophosphatidylserine (By similarity). {ECO:0000250}.;
- Pathway
- Metabolism of lipids;Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Acyl chain remodelling of PE
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- rvis_EVS
- -0.98
- rvis_percentile_EVS
- 8.75
Haploinsufficiency Scores
- pHI
- 0.319
- hipred
- N
- hipred_score
- 0.383
- ghis
- 0.576
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.804
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abhd4
- Phenotype
Gene ontology
- Biological process
- lipid catabolic process;phosphatidylethanolamine acyl-chain remodeling;lipid homeostasis
- Cellular component
- endoplasmic reticulum membrane;lipid droplet
- Molecular function
- hydrolase activity;carboxylic ester hydrolase activity